Adam Levy - Nov 11, 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Signature
/s/ Adam Levy
Stock symbol
MLYS
Transactions as of
Nov 11, 2025
Transactions value $
-$3,873,282
Form type
4
Date filed
11/13/2025, 07:01 PM
Previous filing
Oct 15, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Levy Adam Scott CFO and Secretary 150 N. RADNOR CHESTER ROAD,, SUITE F200, RADNOR /s/ Adam Levy 2025-11-13 0001693134

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Options Exercise $210K +20.5K +61.76% $10.20 53.8K Nov 11, 2025 Direct F1
transaction MLYS Common Stock Options Exercise $551K +34.4K +63.95% $16.00 88.2K Nov 11, 2025 Direct
transaction MLYS Common Stock Options Exercise $628K +44.1K +49.96% $14.25 132K Nov 11, 2025 Direct
transaction MLYS Common Stock Options Exercise $102K +6.61K +5% $15.44 139K Nov 11, 2025 Direct
transaction MLYS Common Stock Sale -$42.6K -1.02K -0.73% $42.00 138K Nov 11, 2025 Direct
transaction MLYS Common Stock Sale -$473K -11.3K -8.19% $41.87 127K Nov 11, 2025 Direct F2
transaction MLYS Common Stock Sale -$66.6K -1.56K -1.23% $42.68 125K Nov 11, 2025 Direct F3
transaction MLYS Common Stock Sale -$539K -13K -10.36% $41.65 112K Nov 11, 2025 Direct F4
transaction MLYS Common Stock Sale -$359K -8.49K -7.57% $42.34 104K Nov 11, 2025 Direct F5
transaction MLYS Common Stock Sale -$180K -4.14K -4% $43.50 99.5K Nov 11, 2025 Direct F6
transaction MLYS Common Stock Sale -$382K -8.46K -8.5% $45.18 91K Nov 11, 2025 Direct F7
transaction MLYS Common Stock Sale -$1.79M -38.9K -42.74% $45.93 52.1K Nov 11, 2025 Direct F8
transaction MLYS Common Stock Sale -$1.53M -32.7K -62.78% $46.88 19.4K Nov 11, 2025 Direct F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLYS Stock Option Options Exercise $0 -20.5K -13.15% $0.00 136K Nov 11, 2025 Common Stock 20.5K $10.20 Direct F10, F11
transaction MLYS Stock Option Options Exercise $0 -34.4K -62.48% $0.00 20.7K Nov 11, 2025 Common Stock 34.4K $16.00 Direct F12, F13
transaction MLYS Stock Option Options Exercise $0 -44.1K -32.49% $0.00 91.6K Nov 11, 2025 Common Stock 44.1K $14.25 Direct F12, F14
transaction MLYS Stock Option Options Exercise $0 -6.61K -57.5% $0.00 4.89K Nov 11, 2025 Common Stock 6.61K $15.44 Direct F12, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Since the date of the Reporting Person's last ownership report, 83,598 shares of common stock were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.
F2 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.4500 to $42.2800. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
F3 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.5100 to $42.9150. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
F4 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.0550 to $42.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
F5 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.1000 to $43.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.
F6 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.1700 to $44.0500. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4.
F7 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.4700 to $45.4600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7) to this Form 4.
F8 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.4800 to $46.4725. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (8) to this Form 4.
F9 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.4900 to $47.3600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (9) to this Form 4.
F10 The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant.
F11 Since the date of the Reporting Person's last ownership report, 13,779 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.
F12 The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of common stock subject to the option on each monthly anniversary thereafter.
F13 Since the date of the Reporting Person's last ownership report, 42,442 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.
F14 Since the date of the Reporting Person's last ownership report, 64,329 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.
F15 Since the date of the Reporting Person's last ownership report, 8,499 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.